Data / Federal awards / NAICS 541714 / SHIONOGI INC
SHIONOGI INC: 2 federal contract awards, $156.1 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
SHIONOGI INC (UEI V8H8DT6RCHW6), Florham Park, NJ, received 2 federal prime contract awards with $156.1 million obligated in fiscal years 2024 to 2027, from 2 agencies under 2 NAICS codes. Its largest buyer is Department of Health and Human Services ($156.1 million) and its largest code is NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The request: Every federal contract awarded under NAICS 541714, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- V8H8DT6RCHW6
- Parent organization
- SHIONOGI & COMPANY LIMITED
- Location
- Florham Park, NJ
- Business size
- Other Than Small Business
- Contract awards
- 2
- Obligated
- $156.1 million
- First action in window
- 2023-10-19
- Latest action
- 2026-09-17
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 1 | $156.1 million |
| 325412 | Pharmaceutical Preparation Manufacturing | 1 | $0 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 1 | $156.1 million |
| Department of Veterans Affairs | 1 | $0 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $0 |
| FY2025 | $0 |
| FY2026 | $156.1 million |
Contract awards
All 2 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50126C00004 | Department of Health and Human Services | Definitive Contract | 541714 | LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREATMENT OF DRUG-RESISTANT SECONDARY | $156,103,541 | $156,103,541 | April 6, 2026 | March 10, 2036 | Florham Park, NJ | usaspending.gov |
| 36F79723D0181 | Department of Veterans Affairs | FSS | 325412 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | $0 | $438,010,752 | September 1, 2023 | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 325412
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.